Skip to content

John Carreyrou - Bad Blood (Secrets & Lies in a Silicon Valley Startup) (2nd Hand Paperback)

£4.45
SKU B002127
Synopsis

Named one of the Best Books of The Year by : The New York Times Book Review, Time, Wall Street Journal & Washington Post. The McKinsey Business Book of the Year 2018.

The Story of Elizabeth Holmes & Theranos.

The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multibillion-dollar biotech start-up founded by Elizabeth Holmes - now the subject of the HBO documentary The Inventor - by the prize-winning journalist who first broke the story and pursued it to the end.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose start-up "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier.

Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion.

There was just one problem: The technology didn't work.

A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

Details
  • Format : Standard 2nd Hand Paperback
  • Condition : As New
  • Category : Non-Fiction - Economics, Business & Money
  • Published : 2018 (Picador)
  • ISBN : 9781509868087
  • SKU : B002127
  • PPC : SP350gm
  • RRP : £9.99
  • Quantity Available : 1 only.
External Reviews

"The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion." - Bill Gates.

The Author

John Carreyrou is a Pulitzer Prize winning French-American journalist and writer. He worked for The Wall Street Journal for 20 years between 1999 and 2019 and has been based in Brussels, Paris, and New York City.